BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38472489)

  • 1. A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer.
    Wu R; Li D; Zhang S; Wang J; Chen K; Tuo Z; Miyamoto A; Yoo KH; Wei W; Zhang C; Feng D; Han P
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):123. PubMed ID: 38472489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer.
    Zhu W; Feng D; Shi X; Li D; Wei Q; Yang L
    Front Oncol; 2022; 12():1042118. PubMed ID: 36578929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-cancer analysis of the oncogenic and immunological roles of apolipoprotein F (APOF) in human cancer.
    Shi X; Feng D; Li D; Han P; Yang L; Wei W
    Eur J Med Res; 2023 Jun; 28(1):190. PubMed ID: 37312170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 6. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
    Zhao H; Xie R; Zhang C; Lu G; Kong H
    Front Genet; 2022; 13():989460. PubMed ID: 36159971
    [No Abstract]   [Full Text] [Related]  

  • 7. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors.
    Zhang Z; Wang Z; Liu Y; Zhao L; Fu W
    J Environ Pathol Toxicol Oncol; 2023; 42(2):11-30. PubMed ID: 36749087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer.
    Lei J; Fan Y; Yan C; Jiamaliding Y; Tang Y; Zhou J; Huang M; Ju G; Wu J; Peng C
    Front Genet; 2022; 13():1007696. PubMed ID: 36171885
    [No Abstract]   [Full Text] [Related]  

  • 9. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
    Ju Q; Li XM; Zhang H; Zhao YJ
    Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
    Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
    Front Genet; 2022; 13():993438. PubMed ID: 36685895
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Expression and Prognostic Value of MSH2 in Pan-Cancer Based on Bioinformatics.
    Qiu W; Ding K; Liao L; Ling Y; Luo X; Wang J
    Biomed Res Int; 2021; 2021():9485273. PubMed ID: 34859104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/β-catenin signaling.
    Huang H; Chen Z; Ni X
    Exp Biol Med (Maywood); 2017 Jan; 242(2):194-202. PubMed ID: 27660242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
    Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
    Fei L; Lu Z; Xu Y; Hou G
    Front Genet; 2022; 13():920897. PubMed ID: 36035140
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
    Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
    Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and immunological role of cathepsin S gene in pan‑cancer.
    Liang S; Dang B; Chen S; Mi H
    Oncol Lett; 2024 Jan; 27(1):41. PubMed ID: 38108072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.